Literature DB >> 34417168

Covid-19: UK approves first monoclonal antibody treatment.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2021        PMID： 34417168     DOI： 10.1136/bmj.n2083

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Pharmacological interventions to prevent Covid-19 disease: A rapid review.

Authors:  Karen Cardwell; Eamon O Murchu; Paula Byrne; Natasha Broderick; Kieran A Walsh; Sinéad M O'Neill; Susan M Smith; Patricia Harrington; Máirín Ryan; Michelle O'Neill
Journal:  Rev Med Virol       Date:  2021-09-28       Impact factor: 11.043

2.  Low Dose Pig Anti-Influenza Virus Monoclonal Antibodies Reduce Lung Pathology but Do Not Prevent Virus Shedding.

Authors:  Basudev Paudyal; Adam McNee; Pramila Rijal; B Veronica Carr; Alejandro Nunez; John McCauley; Rodney S Daniels; Alain R Townsend; John A Hammond; Elma Tchilian
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

3.  Exploration of plant-derived natural polyphenols toward COVID-19 main protease inhibitors: DFT, molecular docking approach, and molecular dynamics simulations.

Authors:  Yufei Ma; Yulian Tao; Hanyang Qu; Cuihong Wang; Fei Yan; Xiujun Gao; Meiling Zhang
Journal:  RSC Adv       Date:  2022-02-14       Impact factor: 3.361

4.  Monoclonal antibodies as a trick or treat for COVID-19? The example of abciximab.

Authors:  Kyriacos Evangelou; Sofia Rozani; Christos Tsagkaris
Journal:  J Med Virol       Date:  2022-01-11       Impact factor: 20.693

5.  Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study.

Authors:  Maria Krutikov; Oliver Stirrup; Hadjer Nacer-Laidi; Borscha Azmi; Chris Fuller; Gokhan Tut; Tom Palmer; Madhumita Shrotri; Aidan Irwin-Singer; Verity Baynton; Andrew Hayward; Paul Moss; Andrew Copas; Laura Shallcross
Journal:  Lancet Healthy Longev       Date:  2022-05-04

Review 6.  Regen-Cov and Covid-19, Update on the Drug Profile and Fda Status: A Mini-Review and Bibliometric Study.

Authors:  Saeid Mezail Mawazi; Jiyauddin Khan; Noordin Othman; Sultan Othman Alolayan; Yaser M Alahmadi; Sultan S Al Thagfan; Sally A Helmy; Roy Rillera Marzo
Journal:  J Public Health Res       Date:  2022-05-16

7.  Repurposing antiviral phytochemicals from the leaf extracts of Spondias mombin (Linn) towards the identification of potential SARSCOV-2 inhibitors.

Authors:  Akwasi Boadu; Clement Agoni; Rajshekhar Karpoormath; Mahmoud Soliman; Manimbulu Nlooto
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.